News

Investment

Building precision nutritional intervention from the ground up

Longeveron announces Q2 results and updates on Alzheimer’s clinical trial

Christian Angermayer on longevity and biotech investment: it’s bouncing back

Top investor talks longevity investment, optimism on SPAC deal, and light at the end of the tunnel for the biotech market.

Lifting the lid on a brain longevity data platform

Insilico Medicine boosts latest funding round to $95 million with Aramco backing

Longevity investment platform opens-up to international investors

Chrysea – delivering precision, healthy lifespan nutritional intervention based on credible scientific evidence

Launchpad for longevity investment and networking

StarkAge Therapeutics collaborates with Lille University to strengthen its platform ExoCise

Occuity launches new investment round as it eyes up product development and new opportunity

Decentralising biotech – Molecule raises $12.7 million in seed funding

Cellino expands executive team as it scales regeneration tech

Genflow Bio set to accelerate future therapeutic developments

Underdog becomes Cyclarity – and moves to the Buck Institute

Basepaws acquisition – exploring longevity beyond human health

Human Longevity and Freedom Acquisition in merger talks

Rubedo Life Sciences expands its Scientific Advisory Board

Juvenescence invest in Chrysea’s mystery ingredient for cellular regeneration

SENISCA raises £2 million in latest seed funding round

Insilico raise $60 million and launch AI-powered drug discovery robotics laboratory

Longevity takes over Davos – and has Gstaad in its sights

BioAge appoints company’s first head of brain aging

Oviva Therapeutics raises $11.5m seed and bags exclusive licensing

World’s first Rejuvenation Startup Summit is announced

Juvenescence and Buck Institute launch company to target heart disease

Tech founders rally into Ultrahuman funding round

Artificial heart developer CARMAT beats €40.5 million funding goal

Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round

Fauna Bio partners with UW Oshkosh in search for novel therapies for disease

Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth

Genflow collaborates with Aging Research Centre to drive sirtuin research

Strategic partnership plans disruptive, personalised AI engine to counter skin aging

Find us here ...

© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.